bpc 157 news 2025 bpc-157 fda A health warning about unregulated peptides has been issued by Australia's BPC-157 Research Peptide | Lyophilized

NHS approach to B12 deficiency: NICE Clinical Knowledge Summaries recommend investigating B12 deficiency in patients presenting with macrocytic anaemia, unexplained neurological symptoms, or risk factors including pernicious anaemia, gastrectomy, malabsorption disorders, metformin use, proton pump inhibitors, or nitrous oxide exposure

Have found exercise helps with dulling the sharpness of the headache

Think of it this way: Not all the B12 in your blood is immediately usable by your body

Because fatigue, pain, dizziness, cognitive problems, and neuropathy may have many causes, evaluation should also consider other infectious, neurologic, autoimmune, endocrine, metabolic, cardiovascular, and medication-related conditions

10 mg vial Concentration: 10 mg 3 mL = 3.333 mg/mL (equivalently 3,333 mcg/mL) Dose in mg: 600 mcg = 0.6 mg Draw volume: 0.6 mg 3.333 mg/mL = 0.18 mL Syringe units: 0.18 mL 100 = 18 units on a U-100 syringe So on the 10 mg vial, one documented dose is a draw to the 18-unit mark